FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy

DSpace Repository

FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy

Author: Mottok, Anja; Jurinovic, Vindi; Farinha, Pedro; Rosenwald, Andreas; Leich, Ellen; Ott, German; Horn, Heike; Klapper, Wolfram; Boesl, Michael; Hiddemann, Wolfgang; Steidl, Christian; Connors, Joseph M.; Sehn, Laurie H.; Gascoyne, Randy D.; Hoster, Eva; Weigert, Oliver; Kridel, Robert
Tübinger Autor(en):
Horn, Heike
Published in: Blood (2018), Bd. 131, H. 2, S. 226-235
Verlagsangabe: Amer Soc Hematology
Language: English
Full text: http://dx.doi.org/10.1182/blood-2017-08-799080
ISSN: 1528-0020
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)